1. |
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc, 2008, 5(2): 136-143.
|
2. |
Mullins AE, Kam K, Parekh A, et al. Obstructive sleep apnea and its treatment in aging: effects on Alzheimer's disease biomarkers, cognition, brain structure and neurophysiology. Neurobiol Dis, 2020, 145: 105054.
|
3. |
Díaz-Román M, Pulopulos MM, Baquero M, et al. Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment. Sleep, 2021, 44(1): zsaa133.
|
4. |
Alfieri A, Srivastava S, Siow RC, et al. Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol, 2011, 589(17): 4125-4136.
|
5. |
Consoli V, Sorrenti V, Grosso S, et al. Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions. biomolecules, 2021, 11(4): 589.
|
6. |
Cuadrado A, Rojo AI, Wells G, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov, 2019, 18(4): 295-317.
|
7. |
Kurucz A, Bombicz M, Kiss R, et al. Heme oxygenase-1 activity as a correlate to exercise-mediated amelioration of cognitive decline and neuropathological alterations in an aging rat model of dementia. Biomed Res Int, 2018, 2018: 7212861.
|
8. |
Song W, Zukor H, Liberman A, et al. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol, 2014, 254: 78-89.
|
9. |
American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
|
10. |
Vanek J, Prasko J, Genzor S, et al. Obstructive sleep apnea, depression and cognitive impairment. Sleep Med, 2020, 72: 50-58.
|
11. |
Li NZ, Wang J, Wang DL, et al. Correlation of sleep microstructure with daytime sleepiness and cognitive function in young and middle-aged adults with obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol, 2019, 276(12): 3525-3532.
|
12. |
Zolotoff C, Voirin AC, Puech C, et al. Intermittent hypoxia and its impact on Nrf2/HIF-1α expression and ABC transporters: an in vitro human blood-brain barrier model study. Cell Physiol Biochem, 2020, 54(6): 1231-1248.
|
13. |
Chang YT, Chen YC, Chen YL, et al. Functional connectivity in default mode network correlates with severity of hypoxemia in obstructive sleep apnea. Brain Behav, 2020, 10(12): e01889.
|
14. |
Branca C, Ferreira E, Nguyen TV, et al. Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease. Hum Mol Genet, 2017, 26(24): 4823-4835.
|
15. |
Pajares M, Jiménez-Moreno N, García-Yagüe ÁJ, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy, 2016, 12(10): 1902-1916.
|
16. |
Pajares M, Rojo AI, Arias E, et al. Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A. Autophagy, 2018, 14(8): 1310-1322.
|
17. |
Schipper HM, Bennett DA, Liberman A, et al. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging, 2006, 27(2): 252-261.
|
18. |
Mueller C, Zhou W, Vanmeter A, et al. The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis, 2010, 19(3): 1081-1091.
|
19. |
Mateo I, Infante J, Sánchez-Juan P, et al. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease. Acta Neurol Scand, 2010, 121(2): 136-138.
|
20. |
Sun W, Zheng J, Ma J, et al. Increased plasma heme oxygenase-1 levels in patients with early-stage Parkinson's disease. Front Aging Neurosci, 2021, 13: 621508.
|
21. |
Dodson M, de la Vega MR, Cholanians AB, et al. Modulating NRF2 in disease: timing is everything. Annu Rev Pharmacol Toxicol, 2019, 59: 555-575.
|
22. |
Jin H, Qi F, Chu F, et al. Morin improves functional recovery after spinal cord injury in rats by enhancing axon regeneration via the Nrf2/HO-1 pathway. Phytother Res, 2021, 35(10): 5754-5766.
|
23. |
Wang Y, Chai Y, He X, et al. Intermittent hypoxia simulating obstructive sleep apnea causes pulmonary inflammation and activates the Nrf2/HO-1 pathway. Exp Ther Med, 2017, 14(4): 3463-3470.
|
24. |
Zhou L, Ouyang R, Luo H, et al. Dysfunction of Nrf2-ARE signaling pathway: potential pathogenesis in the development of neurocognitive impairment in patients with moderate to severe obstructive sleep apnea-hypopnea syndrome. Oxid Med Cell Longev, 2018, 2018: 3529709.
|